Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012)
Opko Health (OPK) reported Preferred Stock Liabilities of $24.4 million for Q4 2012, little changed on a YoY basis from $24.4 million in Q1 2012, and little changed quarter-over-quarter from $24.4 million in Q3 2012.
Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012) Analysis & Trends
Opko Health has reported Preferred Stock Liabilities for 2 years, with the latest figure at $24.4 million in Q4 2012.
- For the quarter ending Q4 2012, Preferred Stock Liabilities changed 0.0% year-over-year to $24.4 million; the trailing twelve-month figure through Dec 2012 stood at $24.4 million (changed 0.0% YoY), and the FY2012 full-year result was $24.4 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities for Q4 2012 stood at $24.4 million, roughly flat from $24.4 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $24.4 million in Q4 2011, with the low at $24.4 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 24.39 Mn |
| Sep 30, 2012 | 24.39 Mn |
| Jun 30, 2012 | 24.39 Mn |
| Dec 31, 2011 | 24.39 Mn |